{"transactions":[{"id":725581,"issuer":{"id":3826,"kind":"organization","name":"Stevanato Group S.p.A."},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-26T10:04:06.000Z","date":"2026-06-15","kind":"sale","planned":false,"acquired":false,"shares":1493,"price":17.09,"value":25515.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents ordinary shares sold by the Reporting Person to cover tax obligations associated with the grant of ordinary shares."}],"balance_after":26991,"source":{"system":"sec-edgar","filing":"0001193125-26-283783","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1849853/000119312526283783/ownership.xml","form_type":"4"}},{"id":725580,"issuer":{"id":3826,"kind":"organization","name":"Stevanato Group S.p.A."},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-26T10:04:06.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":4975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents ordinary shares granted as equity compensation in connection with the Reporting Person's service as director."}],"balance_after":28484,"source":{"system":"sec-edgar","filing":"0001193125-26-283783","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849853/000119312526283783/ownership.xml","form_type":"4"}},{"id":1761743,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-11T14:07:26.000Z","date":"2023-10-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":71736,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per Share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per Share exercise price of such option and (ii) one CVR. (continued in footnote 5)"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"(Continued from footnote 4) Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per Share exercise price greater than or equal to the Cash Amount, and less than $2.71, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, minus the per Share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per Share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per Share exercise price of such option and (ii) one CVR. (continued in footnote 5)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"(Continued from footnote 4) Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per Share exercise price greater than or equal to the Cash Amount, and less than $2.71, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, minus the per Share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":0.3501,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":71736},"source":{"system":"sec-edgar","filing":"0001140361-23-047735","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000114036123047735/form4.xml","form_type":"4"}},{"id":1761742,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-11T14:07:26.000Z","date":"2023-10-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":34663,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per Share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per Share exercise price of such option and (ii) one CVR. (continued in footnote 5)"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"(Continued from footnote 4) Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per Share exercise price greater than or equal to the Cash Amount, and less than $2.71, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, minus the per Share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per Share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per Share exercise price of such option and (ii) one CVR. (continued in footnote 5)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"(Continued from footnote 4) Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per Share exercise price greater than or equal to the Cash Amount, and less than $2.71, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, minus the per Share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":1.01,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":34663},"source":{"system":"sec-edgar","filing":"0001140361-23-047735","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000114036123047735/form4.xml","form_type":"4"}},{"id":1761741,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-10-11T14:07:26.000Z","date":"2023-10-10","kind":"other","planned":false,"acquired":false,"shares":47824,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This line item represents unvested restricted stock awards (\"RSAs\") held by the Reporting Person that were tendered pursuant to the Offer. Pursuant to the terms of the Merger Agreement, at the Effective Time, each unvested RSA that was outstanding immediately prior to the Effective Time and not validly tendered in the Offer was cancelled and converted into the right to receive the Merger Consideration, subject to withholding of applicable taxes and without interest."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This line item represents unvested restricted stock awards (\"RSAs\") held by the Reporting Person that were tendered pursuant to the Offer. Pursuant to the terms of the Merger Agreement, at the Effective Time, each unvested RSA that was outstanding immediately prior to the Effective Time and not validly tendered in the Offer was cancelled and converted into the right to receive the Merger Consideration, subject to withholding of applicable taxes and without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-047735","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000114036123047735/form4.xml","form_type":"4"}},{"id":1761740,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-10-11T14:07:26.000Z","date":"2023-10-10","kind":"other","planned":false,"acquired":false,"shares":27954,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 14, 2023, by and among the Issuer, Harmony Biosciences Holdings, Inc., a Delaware corporation (\"Parent\") and Xylophone Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), Merger Sub completed a tender offer (the \"Offer\") for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, effective as of October 10, 2023 (the \"Effective Time\" with the Issuer surviving the merger). (continued in footnote 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive (a) $1.1059 per Share (the \"Cash Amount\") in cash, subject to any applicable withholding taxes and without interest, plus (b) one contingent value right (each, a \"CVR\") per Share (the \"CVR Amount\" and together with the Cash Amount, the \"Merger Consideration\"), which represents the right to receive up to approximately $2.5444 per Share in the form of one or more potential contingent payments, in cash, subject to any applicable withholding taxes and without interest, upon the achievement of certain milestones (such applicable payment, each, a \"Milestone Payment\")."}],"balance_after":47824,"source":{"system":"sec-edgar","filing":"0001140361-23-047735","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000114036123047735/form4.xml","form_type":"4"}},{"id":1854102,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T20:29:18.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":71736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in full upon the earlier of (i) June 13, 2024 or (ii) the day before the Company's 2024 annual meeting of stockholders."}],"balance_after":71736,"derivative":{"exercise_price":0.3501,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":71736},"source":{"system":"sec-edgar","filing":"0001062993-23-013665","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000106299323013665/form4.xml","form_type":"4"}},{"id":1854101,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T20:29:18.000Z","date":"2023-06-14","kind":"sale","planned":false,"acquired":false,"shares":115,"price":0.3481,"value":40.0315,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction represents shares required to be sold by the Reporting Person to satisfy certain equity plan administrator fees and taxes in connection with the vesting of shares of restricted stock. This sale was mandated by the equity plan administrator and does not represent a discretionary trade by the Reporting Person."}],"balance_after":75778,"source":{"system":"sec-edgar","filing":"0001062993-23-013665","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000106299323013665/form4.xml","form_type":"4"}},{"id":1854100,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T20:29:18.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":47824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock award vests in full upon the earlier of (i) June 13, 2024 or (ii) the day before the Company's 2024 annual meeting of stockholders."}],"balance_after":75893,"source":{"system":"sec-edgar","filing":"0001062993-23-013665","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000106299323013665/form4.xml","form_type":"4"}},{"id":2229781,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T01:52:47.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":34663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in full upon the earlier of (i) June 14, 2023 or (ii) the day before the Company's 2023 annual meeting of stockholders."}],"balance_after":34663,"derivative":{"exercise_price":1.01,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":34663},"source":{"system":"sec-edgar","filing":"0001062993-22-015041","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000106299322015041/form4.xml","form_type":"4"}},{"id":2229780,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T01:52:47.000Z","date":"2022-06-14","kind":"sale","acquired":false,"shares":40,"price":1.01,"value":40.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction represents shares required to be sold by the Reporting Person to satisfy certain equity plan administrator fees in connection with the vesting of shares of restricted stock. This sale was mandated by the equity plan administrator and does not represent a discretionary trade by the Reporting Person."}],"balance_after":28069,"source":{"system":"sec-edgar","filing":"0001062993-22-015041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000106299322015041/form4.xml","form_type":"4"}},{"id":2229779,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T01:52:47.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":23109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock award vests in full upon the earlier of (i) June 14, 2023 or (ii) the day before the Company's 2023 annual meeting of stockholders."}],"balance_after":28109,"source":{"system":"sec-edgar","filing":"0001062993-22-015041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000106299322015041/form4.xml","form_type":"4"}},{"id":2612800,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-05T21:27:06.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full upon the earlier of (i) August 3, 2022, or (ii) the day before the Company's 2022 annual meeting of stockholders."}],"balance_after":7500,"derivative":{"exercise_price":4.44,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001192482-21-000645","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000119248221000645/edgar.xml","form_type":"4"}},{"id":2612799,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-05T21:27:06.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock award vests in full upon the earlier of (i) August 3, 2022, or (ii) the day before the Company's 2022 annual meeting of stockholders."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001192482-21-000645","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000119248221000645/edgar.xml","form_type":"4"}},{"id":3113183,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-11T21:38:32.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of (i) June 10, 2021 and (ii) the day before the Company's 2021 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":5.21,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001192482-20-000469","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000119248220000469/edgar.xml","form_type":"4"}},{"id":3491117,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-13T20:18:21.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of (i) June 11, 2020, or (ii) the day before the 2020 annual meeting of stockholders of Zynerba Pharmaceuticals, Inc."}],"balance_after":15000,"derivative":{"exercise_price":13.5,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001192482-19-000282","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000119248219000282/edgar.xml","form_type":"4"}},{"id":3800906,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-10-02T20:24:03.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":1334,"price":5.156,"value":6878.104,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option was issued to the reporting person pursuant to the Zynerba Pharmaceuticals, Inc. Non-Employee Director Compensation Policy in lieu of cash retainer of $6,875.00."}],"balance_after":1334,"derivative":{"exercise_price":7.86,"exercise_date":"2018-10-01","expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":1334},"source":{"system":"sec-edgar","filing":"0001192482-18-000455","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000119248218000455/edgar.xml","form_type":"4"}},{"id":3874528,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-03T19:13:26.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":1103,"price":6.235,"value":6877.205,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option was issued to the reporting person pursuant to the Zynerba Pharmaceuticals, Inc. Non-Employee Director Compensation Policy in lieu of cash retainer of $6,875.00."}],"balance_after":1103,"derivative":{"exercise_price":9.7,"exercise_date":"2018-07-02","expiration_date":"2028-07-02","underlying":"Common Stock","underlying_shares":1103},"source":{"system":"sec-edgar","filing":"0001192482-18-000330","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000119248218000330/edgar.xml","form_type":"4"}},{"id":3899321,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-06-11T14:01:36.000Z","date":"2018-06-08","kind":"exercise","acquired":false,"shares":75662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award vests in 4 equal annual installments beginning on 3/22/2011."}],"balance_after":0,"derivative":{"exercise_price":21.34,"expiration_date":"2020-03-22","underlying":"Common Stock","underlying_shares":75662},"source":{"system":"sec-edgar","filing":"0001562180-18-002940","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018002940/primarydocument.xml","form_type":"4"}},{"id":3899320,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Common Stock","published_at":"2018-06-11T14:01:36.000Z","date":"2018-06-08","kind":"sale","acquired":false,"shares":42869,"price":96.09,"value":4119282.21,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $95.76 USD to $96.34 USD; the price reported above reflects the weighted average sale price."}],"balance_after":227812.3342,"source":{"system":"sec-edgar","filing":"0001562180-18-002940","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018002940/primarydocument.xml","form_type":"4"}},{"id":3899319,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Common Stock","published_at":"2018-06-11T14:01:36.000Z","date":"2018-06-08","kind":"exercise","acquired":true,"shares":75662,"price":21.34,"value":1614627.08,"ownership":{"direct":true},"balance_after":270681.3342,"source":{"system":"sec-edgar","filing":"0001562180-18-002940","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018002940/primarydocument.xml","form_type":"4"}},{"id":3901396,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-07T20:32:13.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of (i) June 6, 2019, or (ii) the day before the 2019 annual meeting of stockholders of Zynerba Pharmaceuticals, Inc."}],"balance_after":15000,"derivative":{"exercise_price":11.3,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001192482-18-000276","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000119248218000276/edgar.xml","form_type":"4"}},{"id":3938098,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-05-11T19:28:49.000Z","date":"2018-05-09","kind":"exercise","acquired":false,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award vests in 4 equal annual installments beginning on 2/24/2010."}],"balance_after":0,"derivative":{"exercise_price":16.045,"expiration_date":"2019-02-24","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001562180-18-002453","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018002453/primarydocument.xml","form_type":"4"}},{"id":3938097,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Common Stock","published_at":"2018-05-11T19:28:49.000Z","date":"2018-05-09","kind":"sale","acquired":false,"shares":52000,"price":87.14,"value":4531280.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $86.95 USD to $87.80 USD; the price reported above reflects the weighted average sale price."}],"balance_after":195019.3342,"source":{"system":"sec-edgar","filing":"0001562180-18-002453","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018002453/primarydocument.xml","form_type":"4"}},{"id":3938096,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Common Stock","published_at":"2018-05-11T19:28:49.000Z","date":"2018-05-09","kind":"exercise","acquired":true,"shares":52000,"price":16.045,"value":834340.0,"ownership":{"direct":true},"balance_after":247019.3342,"source":{"system":"sec-edgar","filing":"0001562180-18-002453","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018002453/primarydocument.xml","form_type":"4"}},{"id":3972282,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-04-03T20:15:20.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":1344,"price":5.1145,"value":6873.888,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option was issued to the reporting person pursuant to the Zynerba Pharmaceuticals, Inc. Non-Employee Director Compensation Policy in lieu of cash retainer of $6,875.00."}],"balance_after":1344,"derivative":{"exercise_price":7.98,"exercise_date":"2018-04-02","expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":1344},"source":{"system":"sec-edgar","filing":"0001192482-18-000148","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000119248218000148/edgar.xml","form_type":"4"}},{"id":4042452,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Stock Options (Right to buy)","published_at":"2018-02-22T22:36:55.000Z","date":"2018-02-20","kind":"grant","acquired":true,"shares":17544,"price":89.64,"value":1572644.16,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in 4 equal annual installments beginning on 2/20/2019"}],"balance_after":17544,"derivative":{"exercise_price":89.64,"exercise_date":"2019-02-20","expiration_date":"2028-02-20","underlying":"Common Stock","underlying_shares":17544},"source":{"system":"sec-edgar","filing":"0001562180-18-001149","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018001149/primarydocument.xml","form_type":"4"}},{"id":4056402,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Common Stock","published_at":"2018-02-15T23:14:58.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":4526,"price":93,"value":420918.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"2015 PSU (PP14) award vesting"}],"balance_after":195019.3342,"source":{"system":"sec-edgar","filing":"0001562180-18-001011","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018001011/primarydocument.xml","form_type":"4"}},{"id":4061449,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Common Stock","published_at":"2018-02-14T22:28:23.000Z","date":"2017-11-09","kind":"gift","acquired":false,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":187093.3342,"source":{"system":"sec-edgar","filing":"0001562180-18-000946","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018000946/primarydocument.xml","form_type":"5"}},{"id":4107177,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-04T21:06:44.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":754,"price":8.289,"value":6249.906,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option was issued to the reporting person pursuant to the Zynerba Pharmaceuticals, Inc. Non-Employee Director Compensation Policy in lieu of cash retainer of $6,250.00."}],"balance_after":754,"derivative":{"exercise_price":12.995,"exercise_date":"2018-01-02","expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":754},"source":{"system":"sec-edgar","filing":"0001192482-18-000006","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000119248218000006/edgar.xml","form_type":"4"}},{"id":4135770,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Common Stock","published_at":"2017-12-12T22:02:29.000Z","date":"2017-12-08","kind":"sale","acquired":false,"shares":21000,"price":99.01,"value":2079210.0,"ownership":{"direct":true},"balance_after":190493.3342,"source":{"system":"sec-edgar","filing":"0001562180-17-003845","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017003845/primarydocument.xml","form_type":"4"}},{"id":4194107,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-10-03T20:05:42.000Z","date":"2017-10-02","kind":"grant","acquired":true,"shares":1714,"price":5.47,"value":9375.58,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option was issued to the reporting person pursuant to the Zynerba Pharmaceuticals, Inc. Non-Employee Director Compensation Policy in lieu of cash retainer of $9,375."}],"balance_after":1714,"derivative":{"exercise_price":8.69,"exercise_date":"2017-10-02","expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":1714},"source":{"system":"sec-edgar","filing":"0001123292-17-001492","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000112329217001492/edgar.xml","form_type":"4"}},{"id":4261635,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-06T20:00:33.000Z","date":"2017-07-03","kind":"grant","acquired":true,"shares":882,"price":10.63,"value":9375.66,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option was issued to the reporting person pursuant to the Zynerba Pharmaceuticals, Inc. Non-Employee Director Compensation Policy in lieu of cash retainer of $9,375."}],"balance_after":882,"derivative":{"exercise_price":16.9,"exercise_date":"2017-07-03","expiration_date":"2027-07-03","underlying":"Common Stock","underlying_shares":882},"source":{"system":"sec-edgar","filing":"0001123292-17-001201","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000112329217001201/edgar.xml","form_type":"4"}},{"id":4286839,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-09T21:11:44.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (i) June 7, 2018 and (ii) the day before the 2018 annual meeting of stockholders of Zynerba Pharmaceuticals, Inc."}],"balance_after":15000,"derivative":{"exercise_price":18.77,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001123292-17-001120","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000112329217001120/edgar.xml","form_type":"4"}},{"id":4314844,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-05-18T20:14:16.000Z","date":"2017-05-18","kind":"exercise","acquired":false,"shares":54996,"price":20.85,"value":1146666.6,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":20.85,"exercise_date":"2009-02-26","expiration_date":"2018-02-26","underlying":"Common Stock","underlying_shares":54996},"source":{"system":"sec-edgar","filing":"0001562180-17-001995","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017001995/primarydocument.xml","form_type":"4"}},{"id":4314843,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Common Stock","published_at":"2017-05-18T20:14:16.000Z","date":"2017-05-18","kind":"sale","acquired":false,"shares":2600,"price":96.0046,"value":249611.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $96.00 to $96.07, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote."}],"balance_after":211493.3342,"source":{"system":"sec-edgar","filing":"0001562180-17-001995","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017001995/primarydocument.xml","form_type":"4"}},{"id":4314842,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Common Stock","published_at":"2017-05-18T20:14:16.000Z","date":"2017-05-18","kind":"sale","acquired":false,"shares":52396,"price":95.4173,"value":4999484.8508,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $95.00 to $95.99, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote."}],"balance_after":214093.3342,"source":{"system":"sec-edgar","filing":"0001562180-17-001995","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017001995/primarydocument.xml","form_type":"4"}},{"id":4314841,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Common Stock","published_at":"2017-05-18T20:14:16.000Z","date":"2017-05-18","kind":"exercise","acquired":true,"shares":54996,"price":20.85,"value":1146666.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":266489.3342,"source":{"system":"sec-edgar","filing":"0001562180-17-001995","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017001995/primarydocument.xml","form_type":"4"}},{"id":4360418,"issuer":{"id":109058,"kind":"organization","name":"Zynerba Pharmaceuticals, Inc.","symbol":"ZYNE"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-04-04T20:13:05.000Z","date":"2017-04-03","kind":"grant","acquired":true,"shares":734,"price":12.77,"value":9373.18,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option was issued to the reporting person pursuant to the Zynerba Pharmaceuticals, Inc. Non-Employee Director Compensation Policy in lieu of cash retainer of $9,375."}],"balance_after":734,"derivative":{"exercise_price":20.32,"exercise_date":"2017-04-03","expiration_date":"2027-04-03","underlying":"Common Stock","underlying_shares":734},"source":{"system":"sec-edgar","filing":"0001123292-17-000802","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260426/000112329217000802/edgar.xml","form_type":"4"}},{"id":4434146,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Stock Options (Right to buy)","published_at":"2017-02-22T20:18:46.000Z","date":"2017-02-21","kind":"grant","acquired":true,"shares":19512,"price":83.47,"value":1628666.64,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in 4 equal annual installments beginning on 2/21/2018."}],"balance_after":19512,"derivative":{"exercise_price":83.47,"exercise_date":"2018-02-21","expiration_date":"2027-02-21","underlying":"Common Stock","underlying_shares":19512},"source":{"system":"sec-edgar","filing":"0001562180-17-000848","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017000848/primarydocument.xml","form_type":"4"}},{"id":4444378,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Common Stock","published_at":"2017-02-16T20:00:29.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":4623,"price":86.93,"value":401877.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares represent the portion of the Performance Share Unit Award granted in 2014 that have vested for period 13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":211202.1252,"source":{"system":"sec-edgar","filing":"0001562180-17-000734","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017000734/primarydocument.xml","form_type":"4"}},{"id":4521412,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Common Stock","published_at":"2016-12-15T22:38:16.000Z","date":"2016-12-13","kind":"gift","acquired":false,"shares":2400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":206295.3325,"source":{"system":"sec-edgar","filing":"0001562180-16-003811","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218016003811/primarydocument.xml","form_type":"4"}},{"id":4521411,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35169,"kind":"person","name":"FEDERICI WILLIAM J","position":1,"cik":"0001260426","reported_name":"FEDERICI WILLIAM J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CFO"}}],"security":"Common Stock","published_at":"2016-12-15T22:38:16.000Z","date":"2016-12-13","kind":"gift","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":208695.3325,"source":{"system":"sec-edgar","filing":"0001562180-16-003811","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218016003811/primarydocument.xml","form_type":"4"}}]}